Search by...
-
26AprThe metaverse in healthcare: What are the legal implications?Di fronte a così tante opportunità, il diritto si interroga su quali possano essere gli strumenti per gestire e regolare il fenomeno del metaverso nella sanità.
-
18AprAncora incerta la tutela delle opere generate con intelligenze artificialiIl caso del fumetto Zarya of the Dawn, le cui immagini sono state generate con Midjourney, sottoposto all’U.S. Copyright Office. Cosa afferma il Copyright Registration Guidance Usa
-
17AprDelivering drugs to the public outside a pharmacy via a third party: Considerations on a recent ruling by the Criminal Court of CassationIt’s official: Under certain conditions it is not an offense for drugs—including prescription drugs—to be received by and distributed to the public, potentially even outside the pharmacy channel.
-
14AprBest Workplaces Italia 2023: Portolano Cavallo ranks as one of the Best Workplaces for the seventh year in a row and is the only law firm to make the gradeFor the seventh year in a row, Portolano Cavallo is the only law firm to make the list of Best Workplaces™ Italia 2023 from Great Place to Work®. Once again, the firm has been listed among the Best Workplaces in Italy in the category of companies with 50–149 employees.
-
28MarDecentralized clinical trials: Recommendation paper for the implementation of uniform procedures in the European Union publishedOn December 13, the European Commission (EC), the Heads of Medicines Agencies (HMAs), and the European Medicines Agency (EMA) published a document entitled Recommendation paper on decentralised elements in clinical trials (“Recommendations”) to provide Member States further and more detailed guidance on the implementation of procedures for conducting trials outside of traditional clinical trial centers.
-
8MarPortolano Cavallo invests in Private Equity with new partner Andrea GrittiIn the last two years, Portolano Cavallo has handled approximately 80 M&A transactions with double-digit revenue growth in recent years.Article filed under: Private Equity
-
24FebIn the United States, Amazon launched RxPass, a subscription for online purchase of prescription drugs: Could it work in Italy?A few weeks ago, the company introduced a new subscription service that allows subscribers to purchase more than fifty different prescription medicines for a low fixed months fee. Why this would be prohibited in Italy.
-
25JanHow Covid changed telemedicine in Italy: Current status and next stepsDurante e dopo la pandemia, la telemedicina è stata al centro di una serie di importanti interventi del legislatore. A questi si aggiungono ora i fondi del PNRR per 1 mld di euro. Tali risorse e il ruolo delle regioni nel garantirne l’implementazione saranno di fondamentale importanza.
-
23JanThe Italian Parliament approved Law no. 6 of January 13, 2023, setting forth new provisions applicable to distribution agreements in the automotive industryOn January 19, 2023, Italian Law No. 6 of January 13, 2023, containing amendments to Italian Law No. 108 of August 5, 2022, entered into force.Article filed under: Automotive & Mobility
-
16JanUrban air mobility: Implementation of the U-space regulatory packageWithin the context of legislative developments on urban air mobility, as of January 26, 2023, the three implementing regulations adopted by the European Commission in April 2021 will come into force in the European UnionArticle filed under: Automotive & Mobility